1,000
Participants
Start Date
October 31, 2015
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
Gonadotropin-releasing Hormone (GnRH) agonist therapy
This is a non-interventional study. Thus, investigators are free to choose GnRH agonist therapy product, and modalities of administration in accordance with local Summary of Product Characteristics.
Ipsen Central Contact, Paris
Lead Sponsor
Ipsen
INDUSTRY